ARHGAP35 is a novel factor disrupted in human developmental eye phenotypes

Eur J Hum Genet. 2023 Mar;31(3):363-367. doi: 10.1038/s41431-022-01246-z. Epub 2022 Dec 1.

Abstract

ARHGAP35 has known roles in cell migration, invasion and division, neuronal morphogenesis, and gene/mRNA regulation; prior studies indicate a role in cancer in humans and in the developing eyes, neural tissue, and renal structures in mice. We identified damaging variants in ARHGAP35 in five individuals from four families affected with anophthalmia, microphthalmia, coloboma and/or anterior segment dysgenesis disorders, together with variable non-ocular phenotypes in some families including renal, neurological, or cardiac anomalies. Three variants affected the extreme C-terminus of the protein, with two resulting in a frameshift and C-terminal extension and the other a missense change in the Rho-GAP domain; the fourth (nonsense) variant affected the middle of the gene and is the only allele predicted to undergo nonsense-mediated decay. This study implicates ARHGAP35 in human developmental eye phenotypes. C-terminal clustering of the identified alleles indicates a possible common mechanism for ocular disease but requires further studies.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Anophthalmos* / genetics
  • Coloboma* / genetics
  • Eye Abnormalities* / genetics
  • Guanine Nucleotide Exchange Factors / genetics
  • Humans
  • Mice
  • Microphthalmos* / genetics
  • Mutation
  • Phenotype
  • Repressor Proteins / genetics

Substances

  • ARHGAP35 protein, human
  • Repressor Proteins
  • Guanine Nucleotide Exchange Factors